Claim history: what was published, what was changed, why and on what basis.
Site Version 1.0.0 · Data Version 2026.09.09
This is the first published version of the registry. The previous content of each entry is blank; we do not present it as a pre-existing version.
Download the full JSON changelog09.09.2026 · Dodanie
Previously: none - first entry.
New content: Holden et al.'s model (2016) estimated 49,8% myopia in the world population in 2050. It is a projection, not a measurement of the future.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Liang et al.'s model predicts 39,80% myopia in children and adolescents in 2050.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: A European meta-analysis obtained 23,5% cumulative frequency; 18,9% in studies with cycloplegia and 31,2% without it.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Lance, Morgan and Grzybowski ( 2026 ) indicate that global extrapolations may overestimate the future burden of parts of European populations.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: IMI defines myopia as spherical equivalent ≤− 0,50 D and high myopia as ≤− 6,00 D with relaxed accommodation.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The severity of myopia is associated with higher odds ratios of maculopathy, retinal detachment and some other eye diseases.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: A longer eye axis and greater myopia were associated with a greater risk of uncorrectable visual impairment.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Naidoo et al.'s model estimated the potential loss of productivity due to uncorrected myopia to be 244 billion in 2015.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: In the study by Czepita et al. published in 2007, myopia was diagnosed in 13,3% and 4422 students.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The publication regarding 1049 children from the Lublin Voivodeship reports 3,7% myopia.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: In a retrospective study 1518 of eight-year-olds, myopia was found in 16,8% subjects.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Grzybowski and Nowak compiled Polish studies of refraction in minors, showing the diversity of data by age and examination.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Nowak, Jurowski, Grzybowski and Śmigielski described refractive errors in the adult population in central Poland.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The Bedrossian record from 1971 documents the early stage of research on atropine in myopia.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: ATOM showed slower refractive progression and ocular axis increase with atropine 1% than with placebo.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: ATOM2 compared atropine concentrations of 0,5% , 0,1% and 0,01% ; lower concentrations had a milder visual symptom profile.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: After discontinuation of atropine in ATOM2, a rebound dependent on the previous concentration was observed.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: In LAMP atropine 0,05% provided greater control of refraction and axis extension than 0,025% and 0,01% in the first year of the study.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: In the US PEDIG RCT, atropine 0,01% did not slow progression or axis lengthening relative to placebo.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: In the DIMS RCT, the average axis extension over the 2 years was 0,21 mm compared to 0,55 mm with single vision lenses.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: A study of spectacle lenses with aspherical microlenses showed inhibition of progression for the HAL design compared to single vision lenses.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The three-year RCT MiSight showed slower growth of the defect and the eye axis with the tested one-day dual-focus lenses.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: In BLINK, soft lenses with high addition + 2,50 D inhibited progression more strongly than the tested single vision and medium addition lenses.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: A review of prospective studies of soft lenses in children estimated microbial keratitis at 2,7 per 10 000 patient-years.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: In ROMIO, the average axis gain was 0,36 mm in orthokeratology and 0,63 mm in the single vision group over 2 years.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Additional 40 minutes of outdoor activity on school days was associated with lower incidence in an RCT: 30,4% vs. 39,5% over 3 years.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: In the multicenter RCT RLRL, the mean adjusted axis gain at 1 year was 0,13 mm versus 0,38 mm in the control group.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Follow-up observation of RLRL showed maintenance of the effect in those continuing and rebound in some people after discontinuation.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Bilateral visual impairment and retinal changes have been described following the use of RLRL; improvement was observed after exposure was discontinued.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: RLRL safety review included 20 research; 1436 participants received therapy. No permanent vision loss was reported in the analyzed corpus.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Australian RCT pilot showed less axis gain in the RLRL group; extends data beyond Chinese populations.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: A Spanish RCT showed greater axis control when RLRL was added to orthokeratology than with orthokeratology alone.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The real-world study includes groups with different durations of RLRL use, including 91 participants treated with at least 3 years.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The AOSLO study showed no significant loss of cone density or differences in the examined microcirculation parameters after at least 8 months of RLRL.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The study compares RLRL with atropine 0,01% in a crossover regimen.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: In a retrospective analysis, DIMS + RLRL was associated with greater axis control than either method alone.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: RCT meta-analysis showed additional inhibition of axis lengthening for low concentration atropine with orthokeratology compared to orthokeratology alone.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Cochrane 2025 indicates that pharmacological and optical interventions may reduce progression, but the certainty of results and long-term data are mixed.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: IMI 2025 organizes optical, pharmacological, environmental and light strategies and the state of research on their effects.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: ESO and IMI present a framework for the selection of management, prevention and monitoring of myopia progression.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The ESO/IMI Supplement organizes the pathway for risk assessment, intervention and control in the management of myopia.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The publication by Zhang et al. from 2026 describes multicenter real-world data with follow-up dating back to 5 years.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: SPECS 2030 addresses access to refractive care more broadly; includes services, staff, education, costs and monitoring.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The pilot "Good to see" received funding 1,1 PLN million and concerned children in the Lublin Voivodeship.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: MEN in 2022 summarized the "Good to See" pilot: 1052 covered children from 10 schools.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: School prevention includes, among others: visual acuity, strabismus and color vision test.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The Chancellery of the Prime Minister describes the project of changes in the organization of health care for students and the problems of its availability.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The Supreme Audit Office audit identified organizational problems and problems with further proceedings after incorrect school test results.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: AOTMiT publishes an opinion on the local program for the prevention of vision and hearing defects in the Żary commune for the years 2026–2030.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: NMPP has been operational since 2001. MOH reported the myopia rate 26% in Primary 1 in 2023 and screening and education.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: China's 2026–2030 plan outlines vision screening, electronic documentation, and myopia targets by age.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The September MOE announcement 2026 gives 49,9% student myopia in 2025 compared to 53,6% in 2018.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Taiwan's official materials promote daily outdoor time and regular eye check-ups for children.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: Student Health Service has been operational since 1995; an annual health assessment covers vision and referrals for follow-up care.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: MEXT provides access rules for individual student myopia testing data from fiscal years 2021–2023.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The MPC describes the right to accessible information about proposed and possible methods and the foreseeable consequences of their use or omission.
Reason: first edition; request linked to source and constraint.
09.09.2026 · Dodanie
Previously: none - first entry.
New content: The corpus of official sources reviewed did not find support for a sustainable, dedicated, nationwide pediatric myopia control system with monitoring and goals comparable to the Singapore and China models.
Reason: first edition; request linked to source and constraint.
2026-09-11
Previously: No structured publishers for publications; some authors described with initials.
After change: Supplemented publishers 41 of publications from DOI and available expanded names and ORCID from metadata deposited in Crossref.
Metadata verification after consistent DOI. No clinical outcomes or study limitations were changed.
2026-09-11
Previously: Inconsistent project name, incomplete description SOURCE ZERO, 404 indexable and two error files.
After change: Name #PunktZwrotny2050, full description of SOURCE ZERO methodology, dark footer, one error document 404 with noindex,follow. Other indexable pages and documents.
Publication correction according to the instructions of the author of the project. The date the website content changed is not the date of publication of the research or confirmation of deployment to the server.
2026-09-11
Previously: Funding and conflicts of interest not established within a proven scope.
After change: Funding: Eyerising International. Patent declaration CN110237432A by Dr. Zhu; Eyerising International affiliations with Aung and Zhu.
Verification of the Funding and Disclosure statement sections in the full text and affiliations in PubMed. The results and limitations of the study remain unchanged.
